Using multiple data streams to estimate and forecast SARS-CoV-2 transmission dynamics, with application to the virus spread in Orange County, California.

Near real-time monitoring of outbreak transmission dynamics and evaluation of public health interventions are critical for interrupting the spread of the novel coronavirus (SARS-CoV-2) and mitigating morbidity and mortality caused by coronavirus disease (COVID-19). Formulating a regional mechanistic model of SARS-CoV-2 transmission dynamics and frequently estimating parameters of this model using streaming surveillance data offers one way to accomplish data-driven decision making. For example, to detect an increase in new SARS-CoV-2 infections due to relaxation of previously implemented mitigation measures one can monitor estimates of the basic and effective reproductive numbers. However, parameter estimation can be imprecise, and sometimes even impossible, because surveillance data are noisy and not informative about all aspects of the mechanistic model, even for reasonably parsimonious epidemic models. To overcome this obstacle, at least partially, we propose a Bayesian modeling framework that integrates multiple surveillance data streams. Our model uses both COVID-19 incidence and mortality time series to estimate our model parameters. Importantly, our data generating model for incidence data takes into account changes in the total number of tests performed. We apply our Bayesian data integration method to COVID-19 surveillance data collected in Orange County, California. Our results suggest that California Department of Public Health stay-at-home order, issued on March 19, 2020, lowered the SARS-CoV-2 effective reproductive number $R_{e}$ in Orange County below 1.0, which means that the order was successful in suppressing SARS-CoV-2 infections. However, subsequent "re-opening" steps took place when thousands of infectious individuals remained in Orange County, so $R_{e}$ increased to approximately 1.0 by mid-June and above 1.0 by mid-July.

[1]  A. Doucet,et al.  Particle Markov chain Monte Carlo methods , 2010 .

[2]  Theodore Kypraios,et al.  Bayesian non-parametric inference for stochastic epidemic models using Gaussian Processes , 2016, Biostatistics.

[3]  E. Ionides,et al.  Compound Markov counting processes and their applications to modeling infinitesimally over-dispersed systems , 2010, 1003.0173.

[4]  A. M. Edwards,et al.  Estimating the impact of COVID-19 control measures using a Bayesian model of physical distancing , 2020, medRxiv.

[5]  Vladimir N. Minin,et al.  Fitting stochastic epidemic models to gene genealogies using linear noise approximation. , 2019, The annals of applied statistics.

[6]  O Diekmann,et al.  The construction of next-generation matrices for compartmental epidemic models , 2010, Journal of The Royal Society Interface.

[7]  Oliver Stoner,et al.  Multivariate hierarchical frameworks for modeling delayed reporting in count data , 2019, Biometrics.

[8]  L. Brammer,et al.  Risk Factors for Intensive Care Unit Admission and In-hospital Mortality among Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET) , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  Fred Brauer,et al.  Continuous-Time Age-Structured Models in Population Dynamics and Epidemiology , 2008 .

[10]  G. Marion,et al.  Using model-based proposals for fast parameter inference on discrete state space, continuous-time Markov processes , 2015, Journal of The Royal Society Interface.

[11]  C. Whittaker,et al.  Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand , 2020 .

[12]  C. Whittaker,et al.  Estimates of the severity of coronavirus disease 2019: a model-based analysis , 2020, The Lancet Infectious Diseases.

[13]  D. Brodie,et al.  Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study , 2020, medRxiv.

[14]  C. Newcomer,et al.  Quick Facts , 2020, General Pediatrics Board Review.

[15]  Carl A. B. Pearson,et al.  The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study , 2020, The Lancet Public Health.

[16]  Qianyun Liu,et al.  Emerging coronaviruses: Genome structure, replication, and pathogenesis , 2020, Journal of medical virology.

[17]  Aaron A. King,et al.  Time series analysis via mechanistic models , 2008, 0802.0021.

[18]  Lam Si Tung Ho,et al.  Direct likelihood-based inference for discretely observed stochastic compartmental models of infectious disease , 2016, The Annals of Applied Statistics.

[19]  Michael Höhle,et al.  Bayesian nowcasting during the STEC O104:H4 outbreak in Germany, 2011 , 2014, Biometrics.

[20]  O. Morozova,et al.  A model for COVID-19 transmission in Connecticut , 2020, medRxiv.

[21]  B. Finkenstädt,et al.  Statistical Inference in a Stochastic Epidemic SEIR Model with Control Intervention: Ebola as a Case Study , 2006, Biometrics.

[22]  P. van den Driessche Spatial Structure: Patch Models , 2008, Mathematical Epidemiology.

[23]  Jiqiang Guo,et al.  Stan: A Probabilistic Programming Language. , 2017, Journal of statistical software.

[24]  Nicholas G. Polson,et al.  Tracking Epidemics With Google Flu Trends Data and a State-Space SEIR Model , 2012, Journal of the American Statistical Association.

[25]  S. Pei,et al.  Initial Simulation of SARS-CoV2 Spread and Intervention Effects in the Continental US , 2020, medRxiv.

[26]  Chen Shen,et al.  ข้อสรุปจากบทความ “ผลของมาตรการที่ไม่ใช่ยาในการลดอัตราการตายและความต้องการทรัพยาการทาง สาธารณสุขเนื่องจากโรคโควิด-19” โดย Neil Ferguson และคณะ Review of Ferguson et al ”Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand.” , 2020 .

[27]  C. Agrati,et al.  Immunological and inflammatory profiles in mild and severe cases of COVID-19 , 2020, Nature Communications.

[28]  S. Szpunar,et al.  Predictors for Severe COVID-19 Infection , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  Pierre Del Moral,et al.  Stochastic Epidemic Models inference and diagnosis with Poisson Random Measure Data Augmentation. , 2020, Mathematical biosciences.

[30]  Vladimir N. Minin,et al.  A linear noise approximation for stochastic epidemic models fit to partially observed incidence counts , 2020 .

[31]  N. G. Davies,et al.  The effect of non-pharmaceutical interventions on COVID-19 cases, deaths and demand for hospital services in the UK: a modelling study , 2020, medRxiv.

[32]  Simon Cauchemez,et al.  Likelihood-based estimation of continuous-time epidemic models from time-series data: application to measles transmission in London , 2008, Journal of The Royal Society Interface.

[33]  N. Jewell,et al.  Mobility trends provide a leading indicator of changes in SARS-CoV-2 transmission , 2020, medRxiv.

[34]  Zunyou Wu,et al.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.

[35]  G. Meyerowitz-Katz,et al.  A systematic review and meta-analysis of published research data on COVID-19 infection fatality rates , 2020, International Journal of Infectious Diseases.

[36]  Robert J. Cerfolio,et al.  Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease in New York City , 2020, medRxiv.